Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
Title:
Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study
Author:
Pujol, Jean-Louis Vansteenkiste, Johan Paz-Ares Rodríguez, Luis Gregorc, Vanesa Mazieres, Julien Awad, Mark Jänne, Pasi A. Chisamore, Michael Hossain, Anwar M. Chen, Yanyun Beck, J. Thaddeus